Omeros Corporation
OMER
#6583
Rank
A$1.21 B
Marketcap
A$16.85
Share price
-0.75%
Change (1 day)
202.48%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2026 (TTM): -A$40.03 Million

According to Omeros Corporation's latest financial reports the company's current earnings are A$9.89 Million. In 2025 the company made an earning of -A$0.17 Billion, an increase over its 2024 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$40.03 Million-75.61%
2025 -A$0.17 Billion-27.03%
2024 -A$0.23 Billion9.63%
2023 -A$0.21 Billion-9.57%
2022 -A$0.23 Billion-30.65%
2021 -A$0.33 Billion86.28%
2020 -A$0.18 Billion99.45%
2019 -A$88.01 Million-49.91%
2018 -A$0.18 Billion190.77%
2017 -A$60.43 Million-27.96%
2016 -A$83.88 Million-17.61%
2015 -A$0.11 Billion1.88%
2014 -A$99.93 Million87.56%
2013 -A$53.28 Million
2011 -A$39.02 Million-8.96%
2010 -A$42.86 Million45.03%
2009 -A$29.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.97 B-107,686.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.07 B-43,960.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-A$5.51 Million-83.99%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-A$21.24 Million-38.22%๐Ÿ‡บ๐Ÿ‡ธ USA